JMT Stock Analysis: Jeronimo Martins SGPS | LS
Food Distribution | LS, Portugal | Market Cap: 10.991m EUR | 12M Return: -15.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 24.5M
EPS Trend: -9.0%
Qual. Beats: 0
Rev. Trend: 97.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Jerónimo Martins is a Portugal-based food distribution company operating primarily in Portugal, Poland, and Colombia, with additional presence in Slovakia. Its business is structured across five reportable segments covering retail and cash & carry operations in Portugal and Poland, health and beauty retail in Poland, and food retail in Colombia.
The group runs a multi-brand, multi-format portfolio. Biedronka is its largest banner, operating a chain of food stores, while Pingo Doce serves as its Portuguese supermarket chain and Recheio functions as a cash & carry operator. Other banners include Hebe (health and beauty specialty retail with in-store consultation), Ara (proximity food stores in Colombia), and Jeronymo (coffee shops and kiosks). The company also maintains backward-integration activities in dairy, livestock, aquaculture, fruit and vegetable production, and crop farming, supporting its core retail operations.
Jerónimo Martins was founded in 1792, is headquartered in Lisbon, and operates as a subsidiary of Sociedade Francisco Manuel Dos Santos B.V. As a consumer staples food retailer, the business is positioned in a defensive sector, with its discount-led model in Poland via Biedronka historically serving as the primary growth engine for the group.
- Biedronka same-store sales growth lifts Poland operating margin
- Ara Colombia store rollout accelerates top-line expansion
- Polish zloty weakness pressures euro-translated earnings
| Net Income: 637.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 5.01 > 1.0 |
| NWC/Revenue: -8.43% < 20% (prev -9.25%; Δ 0.82% < -1%) |
| CFO/TA 0.14 > 3% & CFO 2.40b > Net Income 637.0m |
| Net Debt (2.59b) to EBITDA (2.41b): 1.07 < 3 |
| Current Ratio: 0.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (628.4m) vs 12m ago 0.0% < -2% |
| Gross Margin: 20.72% > 18% (prev 20.56%; Δ 0.17% > 0.5%) |
| Asset Turnover: 225.7% > 50% (prev 218.8%; Δ 6.95% > 0%) |
| Interest Coverage Ratio: 3.38 > 6 (EBIT TTM 1.24b / Interest Expense TTM 368.0m) |
| A: -0.18 (Total Current Assets 5.37b - Total Current Liabilities 8.44b) / Total Assets 16.9b |
| B: 0.17 (Retained Earnings 2.85b / Total Assets 16.9b) |
| C: 0.08 (EBIT TTM 1.24b / Avg Total Assets 16.2b) |
| D: 0.25 (Book Value of Equity 3.39b / Total Liabilities 13.3b) |
| Altman-Z'' = 0.14 = B |
| DSRI: 0.91 (Receivables 90.0m/91.0m, Revenue 36.5b/33.8b) |
| GMI: 0.99 (GM 20.56% / 20.72%) |
| AQI: 0.98 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 1.08 (Revenue 36.5b / 33.8b) |
| TATA: -0.10 (NI 637.0m - CFO 2.40b) / TA 16.9b) |
| Beneish M = -3.07 (Cap -4..+1) = AA |
As of July 30, 2026, the stock is trading at EUR 17.49 with a total of 1,265,165 shares traded. Over the past week, the price has changed by +2.52%, over one month by +0.52%, over three months by -10.39% and over the past year by -15.89%.
Current recommended Stop Loss: 16.80 (which is 3.9% or 1.9 ATR below the current price).
Jeronimo Martins SGPS has no consensus analysts rating.
P/E Trailing = 17.3168
P/E Forward = 13.6612
P/S = 0.301
P/B = 3.2144
P/EG = 1.535
Revenue TTM = 36.5b EUR
EBIT TTM = 1.24b EUR
EBITDA TTM = 2.41b EUR
Long Term Debt = 514.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 775.0m EUR (from shortLongTermDebt, last quarter)
Debt = 4.41b EUR (Leases only: 4.41b)
Net Debt = 2.59b EUR (calculated: Debt 4.41b - CCE 1.83b)
Enterprise Value = 13.6b EUR (11.0b + Debt 4.41b - CCE 1.83b)
Interest Coverage Ratio = 3.38 (Ebit TTM 1.24b / Interest Expense TTM 368.0m)
EV/FCF = 10.10x (Enterprise Value 13.6b / FCF TTM 1.34b)
FCF Yield = 9.90% (FCF TTM 1.34b / Enterprise Value 13.6b)
FCF Margin = 3.68% (FCF TTM 1.34b / Revenue TTM 36.5b)
Net Margin = 1.74% (Net Income TTM 637.0m / Revenue TTM 36.5b)
Gross Margin = 20.72% ((Revenue TTM 36.5b - Cost of Revenue TTM 29.0b) / Revenue TTM)
Gross Margin QoQ = 21.05% (prev 20.88%)
Tobins Q-Ratio = 0.80 (Enterprise Value 13.6b / Total Assets 16.9b)
Interest Expense / Debt = 8.34% (Interest Expense 368.0m / Debt 4.41b)
Taxrate = 25.43% (222.0m / 873.0m)
NOPAT = 927.7m (EBIT 1.24b * (1 - 25.43%))
Current Ratio = 0.64 (Total Current Assets 5.37b / Total Current Liabilities 8.44b)
Debt / Equity = 1.30 (Debt 4.41b / totalStockholderEquity, last quarter 3.39b)
Debt / EBITDA = 1.07 (Net Debt 2.59b / EBITDA 2.41b)
Debt / FCF = 1.92 (Net Debt 2.59b / FCF TTM 1.34b)
Total Stockholder Equity = 3.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.94% (Net Income 637.0m / Total Assets 16.9b)
RoE = 20.06% (Net Income TTM 637.0m / Total Stockholder Equity 3.17b)
RoCE = 33.72% (EBIT 1.24b / Capital Employed (Equity 3.17b + L.T.Debt 514.0m))
RoIC = 13.95% (NOPAT 927.7m / Invested Capital 6.65b)
WACC = 6.11% (E(11.0b)/V(15.4b) * Re(6.07%) + D(4.41b)/V(15.4b) * Rd(8.34%) * (1-Tc(0.25)))
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 77.97% ; FCFF base≈988.6m ; Y1≈1.13b ; Y5≈1.67b
[DCF] Fair Price = 35.82 (EV 25.1b - Net Debt 2.59b = Equity 22.5b / Shares 628.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -9.05 | EPS CAGR: -0.45% | SUE: 0.30 | # QB: 0
Revenue Correlation: 97.76 | Revenue CAGR: 9.14% | SUE: 0.02 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.38 | Chg30d=-0.66% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=1.21 | Chg30d=-3.33% | Revisions=-62% | GrowthEPS=+1.5% | GrowthRev=+5.9%
EPS next Year (2027-12-31): EPS=1.35 | Chg30d=-4.02% | Revisions=-62% | GrowthEPS=+11.8% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: -77% (up=0, down=10)